Comparison of the Chemopreventive Efficacies of 1,4-phenylenebis(methylene)selenocyanate and Selenium-Enriched Yeast on 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone Induced Lung Tumorigenesis in A/ J Mouse

Nutrition and Cancer

Volumn 46, Issue 2, 2003, Pages 179-185

  Das, Arunangshu ^a   Desai, Dhimant ^a   Pittman, Brian ^a   Amin, Shantu ^a   El Bayoumy, Karam ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 PHENYLENEBIS(METHYLENE)SELENOCYANATE; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; 6 O METHYLGUANINE; 7 METHYLGUANINE; COTTON SEED OIL; NITROSAMINE; SELENIUM; SELENOMETHIONINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOASSAY; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER INHIBITION; CANCER PREVENTION; CHEMOPROPHYLAXIS; CLINICAL PROTOCOL; CONTROLLED STUDY; DIET; DNA ISOLATION; DNA METHYLATION; DNA METHYLATION INHIBITION; DRUG EFFICACY; EXPERIMENTAL ANIMAL; LUNG CANCER; LUNG CARCINOGENESIS; MAXIMUM TOLERATED DOSE; MOUSE; NONHUMAN; SELENIUM ENRICHED YEAST; TISSUE HOMOGENATE; YEAST;

ANIMALIA; GOSSYPIUM HIRSUTUM; MICROPUS; NICOTIANA TABACUM;

EID: 0345602738     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327914NC4602_11     Document Type: Article

References (32)

1. Hoffmann D, Hoffmann I, and El-Bayoumy K: The less harmful cigarette: a controversial issue. A tribute to Ernst L. Wynder. Chem Res Toxicol 14, 767-790, 2001.
2. Hecht SS: Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol 11, 559-603, 1998.
3. Hoffmann D, Castonguay A, Rivenson A, and Hecht SS: Comparative carcinogenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl) -1-butanone and N′-nitrosonomicotine in Syrian golden hamsters. Cancer Res 41, 2386-2393, 1981.
4. Hecht SS, Rivenson A, Braley J, DiBello J, Adams JD, and Hoffmann D: Induction of oral cavity tumors in F344 rats by tobacco-specific nitrosamines and snuff. Cancer Res 46, 4162-4166, 1986.
5. Hecht SS, Morse MA, Amin S, Stoner GD, Jordan KG, et al.: Rapid single-dose model for lung tumor induction in A/J mice by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and the effect of diet. Carcinogenesis 10, 1901-1904, 1989.
6. Hoffmann D, Brunnemann KD, Prokopczyk B, and Djordjevic MV: Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans. J Toxicol Environ Health 41, 1-52, 1994.
7. Hecht SS: Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 91, 1194-1210, 1999.
8. Atalla A and Maser E: Characterization of enzymes participating in carbonyl reduction of 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) in human placenta. Chem Biol Interact 130-132, 737-748, 2001.
9. Finckh C, Atalla A, Nagel G, Stinner B, and Maser E: Expression and NNK reducing activities of carbonyl reductase and 11beta-hydroxysteroid dehydrogenase type 1 in human lung. Chem Biol Interact 130-132, 761-773, 2001.
10. Ronai ZA, Gradia S, Peterson LA, and Hecht SS: G to A transitions and G to T transversions in codon 12 of the Ki-ras oncogene isolated from mouse lung tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and related DNA methylating and pyridyloxobutylating agents. Carcinogenesis 14, 2419-2422, 1993.
11. Castonguay A, Stoner GD, Schut HA, and Hecht SS: Metabolism of tobacco-specific N-nitrosamines by cultured human tissues. Proc Natl Acad Sci USA 80, 6694-6697, 1983.
12. Smith GB, Castonguay A, Donnelly PJ, Reid KR, Petsikas D, et al.: Biotransformation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in freshly isolated human lung cells. Carcinogenesis 20, 1809-1818, 1999.
13. Hecht SS and Tricker AR: Nitrosamines derived from nicotine and other tobacco alkaloids. In Analytical Determination of Nicotine and Related Compounds and Their Metabolites, Gorrod JW and Jacob P III (eds). Amsterdam: Elsevier, 1999, pp 421-488.
14. Hecht SS, Ye M, Carmella SG, Fredrickson A, Adgate JL, et al.: Metabolites of a tobacco-specific lung carcinogen in the urine of elementary school-aged children. Cancer Epidemiol Biomarkers Prev 10, 1109-1116, 2001.
15. El-Bayoumy K: The protective role of selenium on genetic damage and on cancer. Mutat Res 475, 123-139, 2001.
16. Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, et al.: Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276, 1957-1963, 1996.
17. Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GF, Jr, Slate EH, et al.: Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev 11, 630-639, 2002.
18. Schrauzer GN: Selenomethionine: a review of its nutritional significance, metabolism and toxicity. J Nutr 130, 1653-1656, 2000.
19. El-Bayoumy K, Upadhyaya P, Desai DH, Amin S, and Hecht SS: Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone tumorigenicity in mouse lung by the synthetic organoselenium compound, 1,4-phenylenebis(methylene)selenocyanate. Carcinogenesis 14, 1111-1113, 1993.
20. El-Bayoumy K, Upadhyaya P, Chae YH, Sohn OS, Rao CV, et al.: Chemoprevention of cancer by organoselenium compounds. J Cell Biochem Suppl 22, 92-100, 1995.
21. El-Bayoumy K, Upadhyaya P, Desai DH, Amin S, Hoffmann D, et al.: Effects of 1,4-phenylenebis(methylene)selenocyanate, phenethyl isothiocyanate, indole-3-carbinol, and d-limonene individually and in combination on the tumorigenicity of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung. Anticancer Res 16, 2709-2712, 1996.
22. Prokopczyk B, Cox JE, Upadhyaya P, Amin S, Desai D, et al.: Effects of dietary 1,4-phenylenebis(methylene)selenocyanate on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA adduct formation in lung and liver of A/J mice and F344 rats. Carcinogenesis 17, 749-753, 1996.
23. Rosa JG, Prokopczyk B, Desai DH, Amin SG, and El-Bayoumy K: Elevated 8-hydroxy-2′-deoxyguanosine levels in lung DNA of A/J mice and F344 rats treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and inhibition by dietary 1,4-phenylenebis(methylene)selenocyanate. Carcinogenesis 19, 1783-1788, 1998.
24. Prokopczyk B, Amin S, Desai DH, Kurtzke C, Upadhyaya P, et al.: Effects of 1,4-phenylenebis(methylene)selenocyanate and selenomethionine on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorigenesis in A/J mouse lung. Carcinogenesis 18, 1855-1857, 1997.
25. El-Bayoumy K, Chae YH, Upadhyaya P, Meschter C, Cohen LA, et al.: Inhibition of 7,12-dimethylbenz(a)anthracene-induced tumors and DNA adduct formation in the mammary glands of female Sprague-Dawley rats by the synthetic organoselenium compound, 1,4-phenylenebis(methylene)selenocyanate. Cancer Res 52, 2402-2407, 1992.
26. Prokopczyk B, Rosa JG, Desai D, Amin S, Sohn OS, et al.: Chemoprevention of lung tumorigenesis induced by a mixture of benzo(a)pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by the organoselenium compound 1,4-phenylenebis(methylene)selenocyanate. Cancer Lett 161, 35-46, 2000.
27. Sohn OS, Li H, Surace A, El-Bayoumy K, Upadhyaya P, et al.: Contrasting patterns of selenium excretion by female CD rats treated with chemically related chemopreventive organic selenocyanate compounds. Anticancer Res 15, 1849-1856, 1995.
28. Sohn OS, Fiala ES, Requeijo SP, Weisburger JH, and Gonzalez FJ: Differential effects of CYP2E1 status on the metabolic activation of the colon carcinogens azoxymethane and methylazoxymethanol. Cancer Res 61, 8435-8440, 2001.
29. Dunnett CW: A multiple comparisons procedure for comparing several treatments with a control. J Am Stat Assoc 50, 1096-1121, 1955.
30. El-Bayoumy K, Rao CV, and Reddy BS: Multiorgan sensitivity to anticarcinogenesis by the organoselenium 1,4-phenylenebis(methylene)selenocyanate. Nutr Cancer 40, 18-27, 2001.
31. Rao CV, Wang CQ, Simi B, Rodriguez JG, Cooma I, et al.: Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity. Cancer Res 61, 3647-3652, 2001.
32. Tanaka T, Makita H, Kawabata K, Mori H, and El-Bayoumy K: 1,4-phenylenebis(methylene)selenocyanate exerts exceptional chemopreventive activity in rat tongue carcinogenesis. Cancer Res 57, 3644-3648, 1997.